Health Trials

A EUropean REgistry and Sample Sharing networK to Promote the Diagnosis and Management of Light Chain Amyloidosis (EUREKA)

ConditionAL Amyloidosis
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-99
SponsorFondazione IRCCS Policlinico San Matteo di Pavia

About this trial

A prospective patients' registry collecting all new cases of AL amyloidosis evaluated at referral Centers from across Europe and a sample sharing network will be created to study mechanisms of the disease through the use of advanced molecular technologies and big data analysis tools.

Eligibility criteria

Qualifiers

diagnosis of systemic AL amyloidosis;

treatment-naïve;

age ≥18 years;

ability to understand and willingness to sign an informed consent;

Disqualifiers

non-AL amyloidosis;

previous treatment for AL amyloidosis.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

No trial groups listed

Sponsors and collaborators

Fondazione IRCCS Policlinico San Matteo di Pavia

Lead sponsor

Source ClinicalTrials.gov